1997
Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides)
Quirós P, Jones G, Kacinski B, Braverman I, Heald P, Edelson R, Wilson L. Total skin electron beam therapy followed by adjuvant psoralen/ultraviolet-A light in the management of patients with T1 and T2 cutaneous T-cell lymphoma (mycosis fungoides). International Journal Of Radiation Oncology • Biology • Physics 1997, 38: 1027-1035. PMID: 9276369, DOI: 10.1016/s0360-3016(97)00127-2.Peer-Reviewed Original ResearchConceptsTotal skin electron beam therapyDisease-free survivalT2 patientsCrude relapse rateAdjuvant therapyOverall survivalElectron beam therapyRelapse rateEntire cohortMedian disease-free survivalCutaneous T-cell lymphomaBeam therapySalvage of recurrencesAdjuvant systemic therapyEarly-stage patientsManagement of patientsT-cell lymphomaTopical nitrogen mustardDays/weekCombination of therapiesGy/dayTreatments/weekPUVA patientsMedian followSalvage therapy
1991
Cutaneous T-cell lymphoma
Braverman I. Cutaneous T-cell lymphoma. Current Problems In Dermatology 1991, 3: 184-227. DOI: 10.1016/1040-0486(91)90005-o.Peer-Reviewed Original ResearchCutaneous T-cell lymphomaT-cell lymphomaHelper T cellsSézary syndromeMycosis fungoidesStage diseaseNodal involvementEffective therapyT cellsCharacteristic cutaneous findingsMycosis fungoides variantEarly-stage diseaseLate-stage diseaseChronic inflammatory processTopical nitrogen mustardDevelopment of tumorsExtracorporeal photophoresisSustained remissionVisceral involvementCutaneous findingsStaging procedureClinical featuresCutaneous malignanciesInflammatory processChronic stimulation